Posters
Presentation Type
Poster
Discipline Track
Translational Science
Abstract Type
Program Abstract
Abstract
Purpose: Alzheimer’s Disease (ALZ) is the leading cause of dementia in the aging population, and Latinos have >3 times higher risk to develop dementia than the overall US population. Although several studies have examined for possible causes of this increased risk, lack of comprehensive information plus a reduced number of Latino samples available in each study have hindered the answers.
Description: The University of Texas Rio Grande Valley has joined two large studies looking for multiple biomarkers associated with ALZ: The South Texas Alzheimer’s Center Clinical Data Repository and Biobank (STAC) and the Texas Alzheimer’s Research and Care Consortium (TARCC). We are now collecting clinical data along with neuroimaging and lab biomarkers from each individual enrolled in these studies, with the aim to enroll a large majority of Latinos in our site sample, which will help to elucidate the differences and risk factors inherent to our population in the border. We are also analyzing data from different Latin-American studies to study specific genetic risks, environmental factors, and their interactions.
Partners: UTRGV has partnered with UTHSCSA for the STAC study and with many other academic research institutions at TARCC. We aim to provide experiences of clinical training to our psychology students and residents of medical specialties, as well as analysis opportunities and opening postdoctoral positions related to the development of this field at UTRGV.
Looking Ahead: We expect to generate substantial contributions to the knowledge of cognitive decline in underserved populations, which can lead to improved treatments and better clinical care. Postdoctoral positions will be opening soon at the Institute of Neuroscience.
Academic/Professional Position
Faculty
Mentor/PI Department
Neuroscience
Recommended Citation
Alliey-Rodriguez, Ney; Pirela, Rosa V.; Diaz-Badillo, Alvaro; Lopez Lorenzo, Karla; Garza, Noe; Gilliam, Frank; Manusov, Eron G.; and Maestre, Gladys E., "Alzheimer’s Disease Studies in the Tex-Mex Border: Dissecting a Complex Multifactorial Problem" (2023). Research Symposium. 71.
https://scholarworks.utrgv.edu/somrs/2022/posters/71
Included in
Alzheimer’s Disease Studies in the Tex-Mex Border: Dissecting a Complex Multifactorial Problem
Purpose: Alzheimer’s Disease (ALZ) is the leading cause of dementia in the aging population, and Latinos have >3 times higher risk to develop dementia than the overall US population. Although several studies have examined for possible causes of this increased risk, lack of comprehensive information plus a reduced number of Latino samples available in each study have hindered the answers.
Description: The University of Texas Rio Grande Valley has joined two large studies looking for multiple biomarkers associated with ALZ: The South Texas Alzheimer’s Center Clinical Data Repository and Biobank (STAC) and the Texas Alzheimer’s Research and Care Consortium (TARCC). We are now collecting clinical data along with neuroimaging and lab biomarkers from each individual enrolled in these studies, with the aim to enroll a large majority of Latinos in our site sample, which will help to elucidate the differences and risk factors inherent to our population in the border. We are also analyzing data from different Latin-American studies to study specific genetic risks, environmental factors, and their interactions.
Partners: UTRGV has partnered with UTHSCSA for the STAC study and with many other academic research institutions at TARCC. We aim to provide experiences of clinical training to our psychology students and residents of medical specialties, as well as analysis opportunities and opening postdoctoral positions related to the development of this field at UTRGV.
Looking Ahead: We expect to generate substantial contributions to the knowledge of cognitive decline in underserved populations, which can lead to improved treatments and better clinical care. Postdoctoral positions will be opening soon at the Institute of Neuroscience.